Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Breast Cancer Res Treat ; 148(2): 445-53, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25338320

RESUMEN

Research on the effect of cardiorespiratory (CR) exercise on upper extremity (UE) limb volume is limited in women with breast cancer-related lymphedema (BCRL). The aim of this study was to compare changes in UE volume immediately following a symptom-limited CR treadmill test in women with and without BCRL. As part of a cross-sectional study, 133 women post unilateral BC treatment completed symptom-limited treadmill testing. Bioimpedance spectroscopy (BIS) was used to measure UE resistance before and immediately following treadmill testing. Resistance ratios >1 (unaffected side/affected side) indicate greater volume in the affected limb. T-tests and repeated measures ANOVA were performed to evaluate differences between and within groups. Mean age was 56.2 years (SD 9.4); BMI was 26.13 kg m(-2) (SD 5.04). For women with previously diagnosed BCRL (n = 63), the resistance ratio was 1.116 (SD 0.160) pre-treadmill and 1.108 (SD 0.155) post-treadmill. For women without BCRL (n = 70), the resistance ratio was 0.990 (SD 0.041) pre-treadmill and 1.001 (SD 0.044) post-treadmill. Resistance ratios for women with BCRL were higher than those for women without BCRL at both time points (main effect of group: p < 0.001). No main effects were found for time (p = 0.695). A statistically significant effect was found for the time-by-group interaction (p = 0.002). 78% of the women with BCRL wore a compression garment during testing. Following testing, the women with BCRL demonstrated a non-statistically significant decrease in the resistance ratio, suggesting an immediate decrease in interlimb volume difference. The women without BCRL demonstrated an increase in the resistance ratio.


Asunto(s)
Neoplasias de la Mama/complicaciones , Neoplasias de la Mama/rehabilitación , Impedancia Eléctrica , Prueba de Esfuerzo , Ejercicio Físico , Linfedema/diagnóstico , Sobrevivientes , Extremidad Superior/patología , Neoplasias de la Mama/patología , Neoplasias de la Mama/terapia , Terapia Combinada , Estudios Transversales , Femenino , Estudios de Seguimiento , Humanos , Linfedema/etiología , Persona de Mediana Edad , Estadificación de Neoplasias , Pronóstico
2.
N Engl J Med ; 363(2): 109-22, 2010 Jul 08.
Artículo en Inglés | MEDLINE | ID: mdl-20592293

RESUMEN

BACKGROUND: Testosterone supplementation has been shown to increase muscle mass and strength in healthy older men. The safety and efficacy of testosterone treatment in older men who have limitations in mobility have not been studied. METHODS: Community-dwelling men, 65 years of age or older, with limitations in mobility and a total serum testosterone level of 100 to 350 ng per deciliter (3.5 to 12.1 nmol per liter) or a free serum testosterone level of less than 50 pg per milliliter (173 pmol per liter) were randomly assigned to receive placebo gel or testosterone gel, to be applied daily for 6 months. Adverse events were categorized with the use of the Medical Dictionary for Regulatory Activities classification. The data and safety monitoring board recommended that the trial be discontinued early because there was a significantly higher rate of adverse cardiovascular events in the testosterone group than in the placebo group. RESULTS: A total of 209 men (mean age, 74 years) were enrolled at the time the trial was terminated. At baseline, there was a high prevalence of hypertension, diabetes, hyperlipidemia, and obesity among the participants. During the course of the study, the testosterone group had higher rates of cardiac, respiratory, and dermatologic events than did the placebo group. A total of 23 subjects in the testosterone group, as compared with 5 in the placebo group, had cardiovascular-related adverse events. The relative risk of a cardiovascular-related adverse event remained constant throughout the 6-month treatment period. As compared with the placebo group, the testosterone group had significantly greater improvements in leg-press and chest-press strength and in stair climbing while carrying a load. CONCLUSIONS: In this population of older men with limitations in mobility and a high prevalence of chronic disease, the application of a testosterone gel was associated with an increased risk of cardiovascular adverse events. The small size of the trial and the unique population prevent broader inferences from being made about the safety of testosterone therapy. (ClinicalTrials.gov number, NCT00240981.)


Asunto(s)
Enfermedades Cardiovasculares/inducido químicamente , Testosterona/efectos adversos , Administración Cutánea , Anciano , Anciano de 80 o más Años , Método Doble Ciego , Prueba de Esfuerzo , Geles , Humanos , Hiperlipidemias/complicaciones , Hipertensión/complicaciones , Estimación de Kaplan-Meier , Modelos Logísticos , Masculino , Fuerza Muscular/efectos de los fármacos , Obesidad/complicaciones , Factores de Riesgo , Testosterona/sangre , Testosterona/deficiencia , Testosterona/uso terapéutico , Caminata
3.
Cureus ; 15(9): e45362, 2023 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-37849583

RESUMEN

Background Identifying early signs of a SARS-CoV-2 infection in healthcare workers could be a critical tool in reducing disease transmission. To provide this information, both daily symptom surveys and wearable device monitoring could have utility, assuming there is a sufficiently high level of participant adherence. Purpose The aim of this study is to evaluate adherence to a daily symptom survey and a wearable device (Oura Ring) among healthcare professionals (attending physicians and other clinical staff) and trainees (residents and medical students) in a hospital setting during the early stages of the COVID-19 pandemic. Methods In this mixed-methods observational study, the data were a subset (N=91) of those collected as part of the larger TemPredict Study. Demographic data analyses were conducted with descriptive statistics. Participant adherence to the wearable device protocol was reported as the percentage of days that sleep was recorded, and adherence to the daily survey was reported as the percentage of days with submitted surveys. Comparisons for the primary (wearable and survey adherence of groups) and secondary (adherence patterns among subgroups) outcomes were conducted using descriptive statistics, two-tailed independent t-tests, and Welch's ANOVA with post hoc analysis using Games-Howell. Results Wearable device adherence was significantly higher than the daily symptom survey adherence for most participants. Overall, participants were highly adherent to the wearable device, wearing the device an average of 87.8 ± 11.6% of study nights compared to survey submission, showing an average of 63.8 ± 27.4% of study days. In subgroup analysis, we found that healthcare professionals (HCPs) and medical students had the highest adherence to wearing the wearable device, while medical residents had lower adherence in both wearable adherence and daily symptom survey adherence. Conclusions These results indicated high participant adherence to wearable devices to monitor for impending infection in the course of a research study conducted as part of clinical practice. Subgroup analysis indicated HCPs and medical students maintained high adherence, but residents' adherence was lower, which is likely multifactorial, with differences in work demands and stress contributing to the findings. These results can guide the development of adherence strategies for a wearable device to increase the quality of data collection and assist in disease detection in this and future pandemics.

4.
Sci Rep ; 12(1): 3463, 2022 03 02.
Artículo en Inglés | MEDLINE | ID: mdl-35236896

RESUMEN

Early detection of diseases such as COVID-19 could be a critical tool in reducing disease transmission by helping individuals recognize when they should self-isolate, seek testing, and obtain early medical intervention. Consumer wearable devices that continuously measure physiological metrics hold promise as tools for early illness detection. We gathered daily questionnaire data and physiological data using a consumer wearable (Oura Ring) from 63,153 participants, of whom 704 self-reported possible COVID-19 disease. We selected 73 of these 704 participants with reliable confirmation of COVID-19 by PCR testing and high-quality physiological data for algorithm training to identify onset of COVID-19 using machine learning classification. The algorithm identified COVID-19 an average of 2.75 days before participants sought diagnostic testing with a sensitivity of 82% and specificity of 63%. The receiving operating characteristic (ROC) area under the curve (AUC) was 0.819 (95% CI [0.809, 0.830]). Including continuous temperature yielded an AUC 4.9% higher than without this feature. For further validation, we obtained SARS CoV-2 antibody in a subset of participants and identified 10 additional participants who self-reported COVID-19 disease with antibody confirmation. The algorithm had an overall ROC AUC of 0.819 (95% CI [0.809, 0.830]), with a sensitivity of 90% and specificity of 80% in these additional participants. Finally, we observed substantial variation in accuracy based on age and biological sex. Findings highlight the importance of including temperature assessment, using continuous physiological features for alignment, and including diverse populations in algorithm development to optimize accuracy in COVID-19 detection from wearables.


Asunto(s)
Temperatura Corporal , COVID-19/diagnóstico , Dispositivos Electrónicos Vestibles , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Algoritmos , COVID-19/virología , Femenino , Humanos , Masculino , Persona de Mediana Edad , SARS-CoV-2/aislamiento & purificación , Adulto Joven
5.
Am J Kidney Dis ; 57(1): 113-22, 2011 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-20870330

RESUMEN

BACKGROUND: Exercise capacity as measured by peak oxygen uptake (Vo2(peak)) is low in hemodialysis patients. The present study assesses determinants of VO2(peak) in patients with chronic kidney failure who either changed kidney replacement modality to frequent hemodialysis therapy or received a kidney transplant. STUDY DESIGN: Cohort study with assessment at baseline and 6 months after modality change. SETTING & PARTICIPANTS: Participants included nondiabetic individuals receiving conventional hemodialysis who: (1) remained on conventional hemodialysis therapy (n = 13), (2) changed to short daily hemodialysis therapy (n = 10), or (3) received a transplant (n = 5) and (4) individuals who underwent a pre-emptive transplant (n = 15). Additionally, 34 healthy controls were assessed at baseline only. PREDICTOR: Modality change. MEASUREMENT & OUTCOMES: Exercise capacity, assessed using the physiologic components of the Fick equation (Vo2 = cardiac output × a-vo2(dif), where a-vo2(dif) is arterial to venous oxygen difference) was determined using measurement of Vo2(peak) and cardiac output during symptom-limited exercise testing. Analysis of covariance was used to compare differences in changes in Vo2(peak), cardiac output, heart rate, stroke volume, and a-vo2(dif) at peak exercise between participants who remained on hemodialysis therapy and those who underwent transplant. RESULTS: Transplant was the only modality change associated with a significant change in Vo2(peak), occurring as a result of increased peak cardiac output and reflecting increased heart rate without a change in peak a-vo2(dif) despite increased hemoglobin levels. There were no differences in participants who changed to daily hemodialysis therapy compared with those who remained on conventional hemodialysis therapy. LIMITATIONS: Small nonrandomized study. CONCLUSIONS: Vo2(peak) increases significantly after kidney transplant, but not with daily hemodialysis; this improvement reflects increased peak cardiac output through increased peak heart rate. Despite statistical significance, the increase in Vo2(peak) was not clinically significant, suggesting the need for interventions such as exercise training to increase Vo2(peak) in all patients regardless of treatment modality.


Asunto(s)
Tolerancia al Ejercicio , Fallo Renal Crónico/fisiopatología , Trasplante de Riñón , Consumo de Oxígeno , Diálisis Renal/métodos , Adulto , Nitrógeno de la Urea Sanguínea , Gasto Cardíaco , Creatinina/sangre , Prueba de Esfuerzo , Femenino , Frecuencia Cardíaca , Humanos , Fallo Renal Crónico/sangre , Fallo Renal Crónico/terapia , Masculino , Persona de Mediana Edad , Oxígeno/sangre , Volumen Sistólico
6.
Ann Epidemiol ; 58: 38-41, 2021 06.
Artículo en Inglés | MEDLINE | ID: mdl-33640484

RESUMEN

PURPOSE: Meta-analyses of observational studies reduce the role of chance but also introduce bias because the individual component studies are not randomized. Further, it is plausible that the bias may be different in case-control and cohort studies. We explored these issues in meta-analyses of observational studies of Opioid Use Disorder (OUD). METHODS: From a systematic literature review of 152 published meta-analyses, 11 fulfilled the initial inclusion criteria of observational studies of OUD. Of these, 9 were meta-analyses of case-control studies and 2 were meta-analyses of cohort studies but only 4 (3 case-control and 1 cohort) targeted more than one specific chromosomal location. RESULTS: The meta-analyses of the 3 case-control studies, which included 13 individual studies, identified 12 different single nucleotide polymorphisms on 6 different genes on 5 different chromosomes. None was the same as the gene on Chromosome 15 identified from the meta-analysis of the cohort studies. CONCLUSIONS: These data, from genetic studies, suggest biases are different in meta-analyses of case-control and cohort studies, perhaps due to greater selection bias in case-control studies. These observations have potential importance in the application of meta-analyses to many common and serious diseases, as well as genomics and precision medicine, including OUD.


Asunto(s)
Genómica , Medicina de Precisión , Sesgo , Estudios de Casos y Controles , Estudios de Cohortes , Humanos
7.
Hepatology ; 47(4): 1158-66, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18266250

RESUMEN

UNLABELLED: Nonalcoholic fatty liver disease (NAFLD) has been referred to as the hepatic manifestation of the metabolic syndrome. There is a lower prevalence of metabolic syndrome in individuals with higher health-related fitness (HRF) and physical activity (PA) participation. The relationship between NAFLD severity and HRF or PA is unknown. Our aim was to compare measures of HRF and PA in patients with a histological spectrum of NAFLD severity. Thirty-seven patients with liver biopsy-confirmed NAFLD (18 women/19 men; age = 45.9 +/- 12.7 years) completed assessment of cardiorespiratory fitness (CRF, VO(2peak)), muscle strength (quadriceps peak torque), body composition (%fat), and PA (current and historical questionnaire). Liver histology was used to classify severity by steatosis (mild, moderate, severe), fibrosis stage (stage 1 versus stage 2/3), necroinflammatory activity (NAFLD Activity Score; or=5 NAS2) and diagnosis of NASH by Brunt criteria (NASH versus NotNASH). Analysis of variance and independent t tests were used to determine the differences among groups. Fewer than 20% of patients met recommended guidelines for PA, and 97.3% were classified at increased risk of morbidity and mortality by %fat. No differences were detected in VO(2peak) (x = 26.8 +/- 7.4 mL/g/min) or %fat (x = 38.6 +/- 8.2%) among the steatosis or fibrosis groups. Peak VO(2) was significantly higher in NAS1 versus NAS2 (30.4 +/- 8.2 versus 24.4 +/- 5.7 mL/kg/min, P = 0.013) and NotNASH versus NASH (34.0 +/- 9.5 versus 25.1 +/- 5.7 mL/kg/min, P = 0.048). CONCLUSION: Patients with NAFLD of differing histological severity have suboptimal HRF. Lifestyle interventions to improve HRF and PA may be beneficial in reducing the associated risk factors and preventing progression of NAFLD.


Asunto(s)
Ejercicio Físico/fisiología , Hígado Graso/fisiopatología , Aptitud Física/fisiología , Adulto , Anciano , Composición Corporal/fisiología , Prueba de Esfuerzo , Hígado Graso/patología , Femenino , Fibrosis/fisiopatología , Humanos , Hígado/patología , Masculino , Persona de Mediana Edad , Fuerza Muscular/fisiología
9.
Transplantation ; 82(2): 211-7, 2006 Jul 27.
Artículo en Inglés | MEDLINE | ID: mdl-16858284

RESUMEN

BACKGROUND: Pediatric organ transplant recipients may have elevated cardiovascular (CV) risk. Low cardiorespiratory fitness (CRF) may contribute to CV risk; however, studies of CRF in children following kidney transplantation (KTx) and liver transplantation (LTx) are limited. METHODS: Laboratory testing included assessment of CRF (VO2peak), muscle strength, and body composition (%fat). Field testing (FITNESSGRAM) included the PACER, curl-up, and sit-and-reach tests. Values obtained were compared to sex- and age-based criterion-referenced standards (Healthy Fitness Zone, HFZ). The Previous Day Physical Activity Recall was used to assess after-school physical activity (PA) participation. Independent t tests were used to compare groups. RESULTS: Twenty-five KTx and 11 LTx recipients were tested. The groups were similar in all measures. Both groups demonstrated below normative values for VO2peak and muscle strength. Only 4% of the KTx and 9% of the LTx recipients achieved the HFZ for the PACER and 24% of the KTx and 45% of the LTx attained the HFZ for the curl-up test. Approximately 44% of both groups had percent fat greater than the upper criterion value of the HFZ. Both groups reported spending only 8% of their after-school time participating in physical activity. CONCLUSIONS: Pediatric KTx and LTx recipients have significantly reduced CRF, muscle strength, and physical activity. Routine counseling and encouragement for increased physical activity is recommended as a part of routine care. A randomized clinical exercise intervention trial after pediatric solid organ transplantation is warranted to determine the impact of such lifestyle intervention on improving physical fitness and cardiovascular health.


Asunto(s)
Trasplante de Riñón/fisiología , Trasplante de Hígado/fisiología , Aptitud Física , Adolescente , Niño , Estudios Transversales , Etnicidad , Femenino , Humanos , Masculino , Músculo Esquelético/fisiología , Consumo de Oxígeno , Caracteres Sexuales
10.
Hemodial Int ; 16(3): 377-86, 2012 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22413899

RESUMEN

Patients with end-stage renal disease (ESRD) requiring renal replacement have impaired health-related quality of life (HRQoL), and there is general consensus that HRQoL improves with successful transplant and evidence of improvement with frequent hemodialysis. This study reports changes in HRQoL associated with changes in treatment modality to daily hemodialysis (DHD) and transplant among patients requiring renal replacement. This cohort study had assessments at baseline and 6-month following modality change. Subjects were nondiabetic individuals receiving conventional hemodialysis who (a) remained on conventional hemodialysis (n = 13), (b) changed to daily hemodialysis (DHD) (n = 10), or (c) received a living donor transplant (n = 20). Thirty-four healthy controls were assessed once for comparison. HRQoL was measured using the Kidney Disease Quality of Life Instrument. The Physical Functioning and Physical Composite Scale scores were primary outcomes. Transplantation resulted in significant improvements in six of eight generic scales and the physical composite scale (PCS). Those changing to DHD had significant improvements in Physical Function and PCS scales. Those remaining on dialysis remained lower than controls on all scales except for Vitality; the transplant group remained lower than controls only on the Vitality and General Health scales. Transplant resulted in significant improvements in four of the seven disease-specific scales (symptoms, effects, and burden of kidney disease, work). DHD resulted in improvements in the effects of kidney disease. Modality change to transplant results in significant improvement in HRQoL, achieving levels similar to controls. Change to daily hemodialysis improves only select HRQoL domains and remains low in disease-specific domains.


Asunto(s)
Fallo Renal Crónico/psicología , Fallo Renal Crónico/terapia , Diálisis Renal/métodos , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Calidad de Vida , Ensayos Clínicos Controlados Aleatorios como Asunto
11.
Cancer Clin Oncol ; 1(1): 21-31, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-24058390

RESUMEN

Following breast cancer (BC) treatment, many women develop impairments that may impact cardiorespiratory (CR) fitness. The aims of this study were to 1) evaluate CR fitness in women following BC treatment, 2) evaluate differences in CR fitness in those with and without breast cancer-related lymphedema (BCRL) and compare these to age-matched norms, and 3) evaluate the contribution of predictor variables to CR fitness. 136 women post-BC treatment completed testing: 67 with BCRL, and 69 without. VO2 peak was lower in participants compared to published healthy age-matched norms. VO2 peak was statistically significantly lower in women with BCRL. Age, BMI, meeting recommended exercise criteria, and DASH scores explained 50% of the variance in VO2 peak (R=0.708, p<0.001). Following BC treatment CR fitness may be impaired, more-so in women with BCRL. This should be considered when providing rehabilitation for women following BC treatment as cardiorespiratory fitness has linked to improved health outcomes and survivorship.

12.
J Am Geriatr Soc ; 58(9): 1727-33, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20738436

RESUMEN

OBJECTIVES: To determine whether objectively measured physical activity levels are associated with physical function and mobility in older men. DESIGN: Cross-sectional. SETTING: Academic research center. PARTICIPANTS: Eighty-two community-dwelling men aged 65 and older with self-reported mobility limitations were divided into a low-activity and a high-activity group based on the median average daily physical activity counts of the whole sample. MEASUREMENTS: Physical activity according to triaxial accelerometers; physical function and mobility according to the Short Physical Performance Battery (SPPB), gait speed, stair climb time, and a lift-and-lower task; aerobic capacity according to maximum oxygen consumption (VO(2) max); and leg press and chest press maximal strength and peak power. RESULTS: Older men with higher physical activity levels had a 1.4-point higher mean SPPB score and a 0.35-m/s faster walking speed than those with lower physical activity levels. They also climbed a standard flight of stairs 1.85 seconds faster and completed 60% more shelves in a lift-and-lower task (all P<.01); muscle strength and power measures were not significantly different between the low- and high-activity groups. Correlation analyses and multiple linear regression models showed that physical activity is positively associated with all physical function and mobility measures, leg press strength, and VO(2) max. CONCLUSION: Older men with higher physical activity levels demonstrate better physical function and mobility than their less-active peers. Moreover, physical activity levels are predictive of performance in measures of physical function and mobility in older men. Future work is needed to determine whether modifications in physical activity levels can improve or preserve physical performance in later life.


Asunto(s)
Envejecimiento/fisiología , Hábitos , Actividad Motora/fisiología , Fuerza Muscular/fisiología , Anciano , Estudios Transversales , Prueba de Esfuerzo , Humanos , Masculino , Limitación de la Movilidad , Caminata/fisiología
13.
Cancer Nurs ; 33(4): 245-57, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20467301

RESUMEN

BACKGROUND: Few studies have evaluated an individualized home-based exercise prescription during and after cancer treatment. OBJECTIVE: The purpose of this study was to evaluate the effectiveness of a home-based exercise training intervention, the Pro-self Fatigue Control Program on the management of cancer-related fatigue. INTERVENTIONS/METHODS: Participants (N = 119) were randomized into 1 of 3 groups: group 1 received the exercise prescription throughout the study; group 2 received their exercise prescription after completing cancer treatment; and group 3 received usual care. Patients completed the Piper Fatigue Scale, General Sleep Disturbance Scale, Center for Epidemiological Studies-Depression Scale, and Worst Pain Intensity Scale. RESULTS: All groups reported mild fatigue levels, sleep disturbance, and mild pain, but not depression. Using multilevel regression analysis, significant linear and quadratic trends were found for change in fatigue and pain (ie, scores increased, then decreased over time). No group differences were found in the changing scores over time. A significant quadratic effect for the trajectory of sleep disturbance was found, but no group differences were detected over time. No significant time or group effects were found for depression. CONCLUSIONS: Our home-based exercise intervention had no effect on fatigue or related symptoms associated with cancer treatment. The optimal timing of exercise remains to be determined. IMPLICATIONS FOR PRACTICE: Clinicians need to be aware that some physical activity is better than none, and there is no harm in exercise as tolerated during cancer treatment. Further analysis is needed to examine the adherence to exercise. More frequent assessments of fatigue, sleep disturbance, depression, and pain may capture the effect of exercise.


Asunto(s)
Terapia por Ejercicio/organización & administración , Fatiga/prevención & control , Servicios de Atención de Salud a Domicilio/organización & administración , Neoplasias , Depresión/etiología , Fatiga/diagnóstico , Fatiga/etiología , Femenino , Estudios de Seguimiento , Humanos , Estado de Ejecución de Karnofsky , Persona de Mediana Edad , Neoplasias/complicaciones , Neoplasias/tratamiento farmacológico , Neoplasias/radioterapia , Investigación en Evaluación de Enfermería , Dolor/etiología , Cooperación del Paciente , Prescripciones , Análisis de Regresión , San Francisco , Índice de Severidad de la Enfermedad , Método Simple Ciego , Trastornos del Sueño-Vigilia/etiología , Resultado del Tratamiento
14.
J Clin Endocrinol Metab ; 95(6): 2790-9, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20382680

RESUMEN

CONTEXT: Mobility limitation is associated with increased morbidity and mortality. The relationship between circulating testosterone and mobility limitation and physical performance is incompletely understood. OBJECTIVE: Our objective was to examine cross-sectional and prospective relations between baseline sex hormones and mobility limitations and physical performance in community-dwelling older men. DESIGN, SETTING, AND PARTICIPANTS: We conducted cross-sectional and longitudinal analyses of 1445 men (mean age 61.0 +/- 9.5 yr) who attended Framingham Offspring Study examinations 7 and 8 (mean 6.6 yr apart). Total testosterone (TT) was measured by liquid chromatography tandem mass spectrometry at examination 7. Cross-sectional and longitudinal analyses of mobility limitation and physical performance were performed with continuous (per SD) and dichotomized [low TT and free testosterone (FT) and high SHBG vs. normal] hormone levels. MAIN OUTCOME MEASURES: Self-reported mobility limitation, subjective health, usual walking speed, and grip strength were assessed at examinations 7 and 8. Short physical performance battery was performed at examination 7. RESULTS: Higher continuous FT was positively associated with short physical performance battery score (beta = 0.13; P = 0.008), usual walking speed (beta = 0.02; P = 0.048), and lower risk of poor subjective health [odds ratio (OR) = 0.72; P = 0.01]. In prospective analysis, 1 SD increase in baseline FT was associated with lower risk of developing mobility limitation (OR = 0.78; 95% confidence interval = 0.62-0.97) and progression of mobility limitation (OR = 0.75; 95% confidence interval = 0.60-0.93). Men with low baseline FT had 57% higher odds of reporting incident mobility limitation (P = 0.03) and 68% higher odds of worsening of mobility limitation (P = 0.007). CONCLUSIONS: Lower levels of baseline FT are associated with a greater risk of incident or worsening mobility limitation in community-dwelling older men. Whether this risk can be reduced with testosterone therapy needs to be determined by randomized trials.


Asunto(s)
Limitación de la Movilidad , Fuerza Muscular/fisiología , Testosterona/sangre , Adolescente , Adulto , Anciano , Cromatografía Líquida de Alta Presión , Estudios Transversales , Fuerza de la Mano/fisiología , Salud , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Oportunidad Relativa , Equilibrio Postural/fisiología , Estudios Prospectivos , Globulina de Unión a Hormona Sexual/metabolismo , Espectrometría de Masas en Tándem , Caminata/fisiología
15.
J Phys Act Health ; 5(4): 527-38, 2008 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18648118

RESUMEN

BACKGROUND: Interest in the quantification of physical activity is on the rise. Triaxial accelerometry has frequently been used; however, research on the reliability of these devices is limited. We examine the interunit and intraunit reliability of 22 RT3 triaxial accelerometers using a performance-documented laboratory agitator. METHODS: The RT3 units were tested while moving in 2 directions (antero-posterior, medio-lateral) and speeds (150 and 275 RPM) on a shaker with simultaneous documented performance output for three 24-hour periods. RESULTS: Minimal shaker variance was recorded for all trials (coefficients of variation [CVs] < 0.52%). Our data demonstrate good reliability within RT3s (CVs < 1.81%) but poor reliability among the 22 units (CVs range = 9.5% to 34.7%). CONCLUSIONS: In longitudinal studies, each subject should use the same RT3 unit at each assessment. The use of multiple RT3 units in cross-sectional studies is not recommended because data interpretation would be compromised by the high between-unit variability.


Asunto(s)
Ergometría/instrumentación , Monitoreo Ambulatorio/instrumentación , Actividad Motora , Aceleración , Análisis de Varianza , Humanos , Reproducibilidad de los Resultados
16.
Pediatr Nephrol ; 22(7): 1030-9, 2007 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-17372771

RESUMEN

Studies of exercise capacity in children with chronic kidney disease (CKD) are limited. We tested 25 pediatric kidney transplant (TX) recipients and 15 pediatric dialysis (DX) patients. Nine children in the DX group received kidney transplants and were retested 3 months following surgery (pre/post). Testing involved treadmill testing with measurement of peak oxygen uptake (VO(2peak)), muscle strength, body composition (percent fat), and "field" tests of physical fitness using the FITNESSGRAM, which included the PACER test. Values obtained were compared with gender- and age-based criterion-referenced standards [healthy fitness zone (HFZ)]. The previous day physical activity recall (PDPAR) was used to assess physical activity participation. There were no differences between TX and DX subjects for VO(2peak) and muscle strength measurements, and all values were below the normative values. The TX group achieved significantly higher PACER scores, but only one TX and no DX subjects achieved the HFZ for the PACER test. No improvement in any measures were observed from pre- to post-TX in the nine subjects tested, except for a significant increase in percent fat, which negatively affected the change in muscle strength and VO(2peak). All subjects were physically inactive, with less than 10% of nonschool time being physical activity participation. Pediatric patients with CKD had low exercise capacity, were physically inactive, and gained significant fat weight following TX. Counseling and encouragement for more physical activity is warranted as a part of routine medical care in these children.


Asunto(s)
Diálisis , Ejercicio Físico , Trasplante de Riñón/fisiología , Aptitud Física , Adolescente , Adulto , Composición Corporal/fisiología , Estudios Transversales , Femenino , Humanos , Masculino , Actividad Motora/fisiología , Fuerza Muscular/fisiología , Músculo Esquelético/fisiología , Consumo de Oxígeno/fisiología , Periodo Posoperatorio
17.
Clin Transplant ; 19(1): 1-9, 2005 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15659126

RESUMEN

Many studies have reported improved health-related quality of life (HRQoL) from pre- to immediate post-orthotopic liver transplantation (OLT). However, few studies have evaluated longitudinal changes over the first 2 yr post-OLT and none have simultaneously examined objective measures of health-related fitness. A total of 50 OLT recipients (32 males,18 females; 51.4 +/- 11.8 yr) completed testing at 2, 6, 12, and 24 months post-OLT. Testing included assessment of exercise capacity (peak VO2), quadriceps muscle strength, body composition, physical activity participation, and self-reported functioning (SF-36). Repeated measures of analysis of variance (ANOVA) with post hoc contrasts was performed to determine differences over time and a second ANOVA assessed differences over time between genders. All patients increased peak VO2, quadriceps muscle strength, and percent body fat (p < 0.0001) from 2 to 24 months. Men and women differed in their changes of peak VO2 and percent body fat (p < 0.05). At 24 months, only 50% of the patients reported participating in regular physical activity. All SF-36 physical measures except general health, improved from 2 to 24 months (p < 0.0001). Measures of health-related fitness and QoL improve over the first 2 yr post-OLT with the greatest gains occurring in the first 6 months and all measures remain lower than recommended for cardiovascular and overall health. A randomized clinical trial of lifestyle modifications such as diet and exercise intervention is warranted to determine the impact of such modifications on HRQoL and fitness post-OLT.


Asunto(s)
Trasplante de Hígado , Evaluación de Resultado en la Atención de Salud , Calidad de Vida , Adulto , Composición Corporal , Tolerancia al Ejercicio , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Actividad Motora , Factores Sexuales
18.
AACN Clin Issues ; 13(2): 333-47, 2002 May.
Artículo en Inglés | MEDLINE | ID: mdl-12011603

RESUMEN

End-stage liver disease (ESLD) affects thousands of people in the United States annually. Improvements in survival after liver transplantation have broadened the indications for its use as a proven therapy for ESLD, rapidly increasing the number of transplant candidates. However, the number of patients awaiting transplantation far surpasses the donor supply, resulting in lengthy waiting times. During this wait, these patients experience progressive disease-related decompensation that is often accompanied by malnutrition and reduced physical activity. This chronic disease triad can have profound effects on musculoskeletal complications, such as cachexia and osteoporosis. In the absence of proper interventional strategies before transplantation, these complications can intensify after the transplantation, as a result of continued poor nutrition intake, bed rest, and pharmacotherapies. This article discusses levels of physical functioning and nutrition status in both the pre-and post-transplant populations, the risks associated with current levels, and the roles that diet and activity therapies can have to improve outcomes.


Asunto(s)
Hepatopatías/complicaciones , Trasplante de Hígado , Enfermedades Musculoesqueléticas/terapia , Caquexia/etiología , Caquexia/terapia , Terapia por Ejercicio , Humanos , Hepatopatías/terapia , Atrofia Muscular/etiología , Atrofia Muscular/terapia , Estado Nutricional , Obesidad/etiología , Obesidad/terapia , Osteoporosis/etiología , Osteoporosis/terapia , Aptitud Física , Complicaciones Posoperatorias
19.
Clin Transplant ; 17(3): 225-30, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12780672

RESUMEN

Exercise capacity and muscle function are known to be abnormal in patients with renal disease. We present a case study in which we studied a kidney transplant recipient who received a kidney from his identical twin. Testing included maximal exercise testing with measurement of oxygen uptake (VO2max), isokinetic muscle function testing, body composition analysis using dual energy X-ray absorptiometry (DEXA) imaging and quality of life using The Medical Outcomes Short Form (SF-36) questionnaire. Muscle biopsies were also analysed for fibre composition and size and ultrastructure. We found that the twin recipient had lower values for VO2max, muscle strength, muscle mass and quality of life scales (physical domains) compared with the twin donor. Muscle fibre composition was identical in the twins, however, muscle fibres size was reduced in the twin donor in Type I, and Type IIA fibre types. The twin recipient also showed lower fibre density (volume percentage) and greater intrafibrillar space than the donor. The twins were both sedentary, thus we conclude that the low exercise capacity and abnormalities observed in the recipient are characteristics of renal failure, and not the result of physical deconditioning, nor was it related to prednisone therapy, which may negatively affect muscle function.


Asunto(s)
Enfermedades en Gemelos , Tolerancia al Ejercicio/fisiología , Trasplante de Riñón/fisiología , Donadores Vivos , Músculo Esquelético/patología , Absorciometría de Fotón , Anciano , Biopsia , Composición Corporal , Prueba de Esfuerzo , Humanos , Masculino , Fibras Musculares Esqueléticas/patología , Calidad de Vida , Insuficiencia Renal/fisiopatología , Gemelos Monocigóticos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA